Published online Jul 24, 2023. doi: 10.5306/wjco.v14.i7.259
Peer-review started: February 23, 2023
First decision: March 28, 2023
Revised: May 10, 2023
Accepted: June 13, 2023
Article in press: June 13, 2023
Published online: July 24, 2023
Processing time: 145 Days and 14.1 Hours
The incidence of anal cancer has been increasing in the United States. Smoking is a well-established risk factor; however, the impact of smoking on disease re-currence and outcome has not been well studied. The aim of this study was to assess the association between anal cancer recurrence and cigarette smoking.
To investigate the relationship between cigarette smoking status and anal cancer treatment outcome.
The cancer registry from a single, community hospital was screened for patients with anal cancer between 2010 and 2021. The following characteristics were gathered from the database: Age; sex; cigarette smoking history; American Joint Committee on Cancer Clinical Stage Group; response to therapy; recurrence; time to recurrence; mortality; time to death; and length of follow-up. Patients were divided into the following groups: Current smokers; former smokers; and never smokers. SPSSv25.0 software (IBM Corp., Armonk, NY, United States) was used for statistical analysis.
A total of 95 patients from the database met the screening criteria. There were 37 never smokers, 22 former smokers, and 36 current smokers. There was no difference between groups in regards to race or sex. There was no difference in the American Joint Committee on Cancer Clinical Stage Group between groups. The former smokers were significantly older when compared to never smokers and current smokers (66.5 ± 13.17 vs 57.4 ± 7.82 vs 63.7 ± 13.80, P = 0.011). Former smokers and current smokers had a higher recurrence rate compared to never smokers (30.8% and 20.8% compared to zero, P = 0.009). There was not a significant difference in recurrence between former smokers and current smokers. There was no difference in the mortality, non-response rate, or time to death between the groups.
Our data contributes evidence that cigarette smoking status is associated with increased recurrence for patients with anal cancer.
Core Tip: This retrospective review examined the impact of smoking on anal cancer treatment for 95 patients. Smoking status was associated with a significantly higher rate of anal cancer recurrence after standard treatment. There was not a significant association between smoking status and anal cancer treatment non-response or mortality. Further study is needed to determine if smoking cessation would alter the course of anal cancer or if adjunct therapy would be beneficial in patients with anal cancer and a smoking history.